Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Contact dermatitis in children

INTRODUCTION

Contact dermatitis refers to inflammation of the dermis and epidermis as a result of direct contact between a substance and the surface of the skin. In fact, almost all dermatitis is the result of skin surface injury from epicutaneous exposures. Contact dermatitis is divided into two broad categories: irritant contact dermatitis and allergic contact dermatitis. Irritants cause immediate inflammation of the skin; allergens cause an inflammatory response that is delayed by days.

This topic will discuss irritant and allergic contact dermatitis in children. Contact dermatitis in adults is discussed separately.

(See "Irritant contact dermatitis in adults".)

(See "Basic mechanisms and pathophysiology of allergic contact dermatitis".)

(See "Clinical features and diagnosis of allergic contact dermatitis".)

                        

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Oct 2014. | This topic last updated: May 2, 2013.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Abe T. Studies on skin surface barrier functions. Transepidermal water loss and skin surface lipids during childhood. Chem Pharm Bull (Tokyo) 1978; 26:1659.
  2. de Jongh CM, Khrenova L, Verberk MM, et al. Loss-of-function polymorphisms in the filaggrin gene are associated with an increased susceptibility to chronic irritant contact dermatitis: a case-control study. Br J Dermatol 2008; 159:621.
  3. Seidenari S, Giusti G. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol 1995; 75:429.
  4. Chamlin SL, Kao J, Frieden IJ, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002; 47:198.
  5. Williams HC, Burney PG, Strachan D, Hay RJ. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis. Br J Dermatol 1994; 131:397.
  6. Lynde CW. Moisturizers: what they are and how they work. Skin Therapy Lett 2001; 6:3.
  7. Lodén M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol 2003; 4:771.
  8. Lodén M. Barrier recovery and influence of irritant stimuli in skin treated with a moisturizing cream. Contact Dermatitis 1997; 36:256.
  9. Yilmaz E, Borchert HH. Effect of lipid-containing, positively charged nanoemulsions on skin hydration, elasticity and erythema--an in vivo study. Int J Pharm 2006; 307:232.
  10. Orchard D, Weston WL. The importance of vehicle in pediatric topical therapy. Pediatr Ann 2001; 30:208.
  11. Militello G, Jacob SE, Crawford GH. Allergic contact dermatitis in children. Curr Opin Pediatr 2006; 18:385.
  12. Weston WL, Weston JA, Kinoshita J, et al. Prevalence of positive epicutaneous tests among infants, children, and adolescents. Pediatrics 1986; 78:1070.
  13. Jacob SE, Steele T, Brod B, Crawford GH. Dispelling the myths behind pediatric patch testing-experience from our tertiary care patch testing centers. Pediatr Dermatol 2008; 25:296.
  14. Mortz CG, Lauritsen JM, Bindslev-Jensen C, Andersen KE. Prevalence of atopic dermatitis, asthma, allergic rhinitis, and hand and contact dermatitis in adolescents. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis. Br J Dermatol 2001; 144:523.
  15. Barros MA, Baptista A, Correia TM, Azevedo F. Patch testing in children: a study of 562 schoolchildren. Contact Dermatitis 1991; 25:156.
  16. Silverberg NB, Licht J, Friedler S, et al. Nickel contact hypersensitivity in children. Pediatr Dermatol 2002; 19:110.
  17. Zug KA, McGinley-Smith D, Warshaw EM, et al. Contact allergy in children referred for patch testing: North American Contact Dermatitis Group data, 2001-2004. Arch Dermatol 2008; 144:1329.
  18. Bruckner AL, Weston WL, Morelli JG. Does sensitization to contact allergens begin in infancy? Pediatrics 2000; 105:e3.
  19. Seidenari S, Manzini BM, Motolese A. Contact sensitization in infants: report of 3 cases. Contact Dermatitis 1992; 27:319.
  20. Weston WL, Bruckner A. Allergic contact dermatitis. Pediatr Clin North Am 2000; 47:897.
  21. Tuckermann JP, Kleiman A, Moriggl R, et al. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J Clin Invest 2007; 117:1381.
  22. Bruckner AL, Weston WL. Beyond poison ivy: understanding allergic contact dermatitis in children. Pediatr Ann 2001; 30:203.
  23. Hogan PA, Weston WL. Allergic contact dermatitis in children. Pediatr Rev 1993; 14:240.
  24. Brasch J, Geier J. Patch test results in schoolchildren. Results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG). Contact Dermatitis 1997; 37:286.
  25. Clayton TH, Wilkinson SM, Rawcliffe C, et al. Allergic contact dermatitis in children: should pattern of dermatitis determine referral? A retrospective study of 500 children tested between 1995 and 2004 in one U.K. centre. Br J Dermatol 2006; 154:114.
  26. Wöhrl S, Hemmer W, Focke M, et al. Patch testing in children, adults, and the elderly: influence of age and sex on sensitization patterns. Pediatr Dermatol 2003; 20:119.
  27. Seidenari S, Giusti F, Pepe P, Mantovani L. Contact sensitization in 1094 children undergoing patch testing over a 7-year period. Pediatr Dermatol 2005; 22:1.
  28. Bryden AM, Moseley H, Ibbotson SH, et al. Photopatch testing of 1155 patients: results of the U.K. multicentre photopatch study group. Br J Dermatol 2006; 155:737.
  29. Sharma V, Beyer DJ, Paruthi S, Nopper AJ. Prominent pruritic periumbilical papules: allergic contact dermatitis to nickel. Pediatr Dermatol 2002; 19:106.
  30. Jacob SE, Burk CJ, Connelly EA. Patch testing: another steroid-sparing agent to consider in children. Pediatr Dermatol 2008; 25:81.
  31. Avenel-Audran M, Dutartre H, Goossens A, et al. Octocrylene, an emerging photoallergen. Arch Dermatol 2010; 146:753.
  32. Bruckner AL, Weston WL. Allergic contact dermatitis in children: a practical approach to management. Skin Therapy Lett 2002; 7:3.
  33. Jacob SE, Brod B, Crawford GH. Clinically relevant patch test reactions in children--a United States based study. Pediatr Dermatol 2008; 25:520.
  34. Stables GI, Forsyth A, Lever RS. Patch testing in children. Contact Dermatitis 1996; 34:341.
  35. Sherertz EF. Patch testing children. Pediatr Dermatol 1998; 15:68.
  36. Wolverton SE. Systemic corticosteroids. In: Comprehensive Dermatologic Drug Therapy, Wolverton SE (Ed), WB Saunders, Philadelphia 2001. p.109.
  37. Weston WL, Lane AT, Morelli JG. Color Textbook of Pediatric Dermatology, 4th ed, Mosby-Elsevier, London 2007.
  38. Hachem JP, De Paepe K, Vanpée E, et al. Efficacy of topical corticosteroids in nickel-induced contact allergy. Clin Exp Dermatol 2002; 27:47.
  39. Green C. The effect of topically applied corticosteroid on irritant and allergic patch test reactions. Contact Dermatitis 1996; 35:331.
  40. Ellison JA, Patel L, Ray DW, et al. Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis. Pediatrics 2000; 105:794.
  41. Davis MD, el-Azhary RA, Farmer SA. Results of patch testing to a corticosteroid series: a retrospective review of 1188 patients during 6 years at Mayo Clinic. J Am Acad Dermatol 2007; 56:921.
  42. Meingassner JG, Stütz A. Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases? J Invest Dermatol 1992; 98:851.
  43. Pacor ML, Di Lorenzo G, Martinelli N, et al. Tacrolimus ointment in nickel sulphate-induced steroid-resistant allergic contact dermatitis. Allergy Asthma Proc 2006; 27:527.
  44. FDA Public Health Advisory. Elidel (pimecrolimus) Cream and Protopic (tacrolimus) Ointment, March 2005. www.fda.gov/cder/drug/advisory/elidel_protopic.htm (Accessed on March 29, 2007).
  45. Paul C, Cork M, Rossi AB, et al. Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years. Pediatrics 2006; 117:e118.